Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Simone Battella

3PUBLICATIONS

28CO-AUTHORS

Animal protection (incl. pests and pathogens)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 26, 2021

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults.

Simone Lanini, Stefania Capone, Andrea Antinori

|Jun 02, 2021

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.

Cristina Capuano, Chiara Pighi, Simone Battella

|Jan 18, 2020

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ<sub>c</sub> cytokine stimulation via PI3K/mTOR axis.

Cristina Capuano, Chiara Pighi, Roberta Maggio

Pageof 1

Frequent Collaborators

2 joint publications

Cristina Capuano

2 joint publications

Chiara Pighi

2 joint publications

Gabriella Palmieri

2 joint publications

Ricciarda Galandrini

2 joint publications

Simone Lanini

1 joint publications

Roberta Maggio

1 joint publications

Stefania Morrone

1 joint publications

Angela Santoni

1 joint publications

Stefania Capone

1 joint publications

Emanuele Nicastri

Frequent Collaborators

2 joint publications

Cristina Capuano

2 joint publications

Chiara Pighi

2 joint publications

Gabriella Palmieri

2 joint publications

Ricciarda Galandrini

Top Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on : Feb 14, 2025

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos

Top Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on : Feb 14, 2025

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos